CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Viiv Healthcare's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv Infection9
Feb 15, 2023Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
Jun 5, 2019Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
Aug 22, 2018Antiviral Therapy4
Mar 21, 2018Antiviral Therapy2

Top competitors of Viiv Healthcare

List of top competitors of Viiv Healthcare based on patent oppositions.